Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
March 31, 2004
Primary Completion Date
September 30, 2004
Study Completion Date
September 30, 2004
Conditions
Hypercholesterolemia
Interventions
DRUG
SCH 58235
SCH 58235 10 mg (once daily)
DRUG
pitavastatin
Pitavastatin 2 mg (once daily)
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00653913 - Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED) | Biotech Hunter | Biotech Hunter